|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 31/41 | (2006.01) |
| A61K 31/4178 | (2006.01) | ||
| A61K 31/4184 | (2006.01) | ||
| A61K 31/519 | (2006.01) | ||
| A61P 9/04 | (2006.01) | ||
| A61P 9/10 | (2006.01) | ||
| A61P 3/10 | (2006.01) |
| (11) | Number of the document | 1925303 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08004265.8 |
| Date of filing the European patent application | 2000-08-25 | |
| (97) | Date of publication of the European application | 2008-05-28 |
| (45) | Date of publication and mention of the grant of the patent | 2014-09-24 |
| (46) | Date of publication of the claims translation | 2015-01-26 |
| (30) | Number | Date | Country code |
| 9903028 | 1999-08-27 | SE |
| (72) |
Schoelkens, Bernward, DE
Bender, Norbert, DE
Rangoonwala, Badrudin, DE
Dagenais, Gilles, CA
Gerstein, Hetzel, CA
Ljunggren, Anders, SE
Yusuf, Salim, CA
|
| (73) |
Sanofi-Aventis Deutschland GmbH,
Brüningstra e 50, 65929 Frankfurt am Main,
DE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Angeotenzino II tipo receptorių antagonistai, skirti diabeto prevencijai |
| Use of Angiotensin II type 1 receptor antagonists for the prevention of diabetes |
| Payment date | Validity (years) | Amount | |
| 2017-07-13 | 18 | 347.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2018-08-25 |